It's been a year of bitter medicine for Indian pharma companies with fines worth millions of dollars imposed by various foreign regulators, even as they stitched together deals worth billions of dollars, including the high profile Sun-Ranbaxy ... Business Today India, 1 month ago
Pharma in 2014: Deals worth billions and fines worth millions - Business Standard India, 1 month ago
2014: Pharma Deals Worth Billions, Fines Worth Millions - NDTV Profit, 1 month ago
Ranbaxy's Journey Ranbaxy is an India-based pharmaceutical company. Its subsidiary, Ohm Laboratories in the US, received an approval to launch a cheaper version of Novartis blood pressure and heart attack treatment pill, Diovan, from the US Food ...International Business Times India, 1 month ago Sun Pharma, Ranbaxy to sell 7 products to meet CCI conditions ZeeNews.com, 1 month ago
on your WebpageAdd Widget >Get your members hooked!